Unknown

Dataset Information

0

The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation.


ABSTRACT: BACKGROUND:Previous studies indicated low-intensity warfarin (INR target of 1.5-2.5) achieved reduced hemorrhage without increasing thromboembolism for Asians with non-valvular atrial fibrillation (NVAF). Whether non-vitamin K antagonist oral anticoagulant (NOAC) is superior to warfarin with good time in the therapeutic range (TTR) based on lower INR target among Asians with NVAF remains unknown. METHODS:In this retrospective study collected from Taiwan Chang Gung Memorial Hospital Database, there were 5,197, 3,396, and 9,898 consecutive patients taking warfarin, NOAC, and no-treatment, respectively, from January 1, 2000 to December 31, 2015. Propensity-score weighting was used across the study groups. Patients were followed until the first occurrence of study outcome or end date of study. RESULTS:Among those patients taking warfarin, the mean"artificial" TTR (aTTR) based on a lower INR target of 1.5-2.5 was 44.4±33.3%. Total 79.2% (n = 2,690) patients took low-dose NOACs. Patients with aTTR in the range from <30%(34.0%), 30-50%(17.6%), 50-70%(23.5%) to >70%(24.9%) showed decremental risks of efficacy and composite outcome compared with no-treatment. The risk of major bleeding didn't increase among patients with top aTTR>70% compared to no-treatment. The NOAC group showed a comparable risk of composite outcome to the warfarin subgroup with aTTR of >70% (P = 0.485). The NOAC group had a lower risk of composite outcome than warfarin subgroup with TTR of>70% based on the INR target of 2.0-3.0 (P = 0.004). CONCLUSIONS:NOACs showed a comparable risk of efficacy, safety, and composite outcome to well-managed warfarin based on a lower INR target of 1.5-2.5 in Asians with NVAF taking oral anticoagulants.

SUBMITTER: Chan YH 

PROVIDER: S-EPMC6422299 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation.

Chan Yi-Hsin YH   Lee Kuang-Tso KT   Kao Yi-Wei YW   Huang Chien-Ying CY   Chen Yung-Lung YL   Hang Samuel Chi-Ling SC   Chu Pao-Hsien PH  

PloS one 20190318 3


<h4>Background</h4>Previous studies indicated low-intensity warfarin (INR target of 1.5-2.5) achieved reduced hemorrhage without increasing thromboembolism for Asians with non-valvular atrial fibrillation (NVAF). Whether non-vitamin K antagonist oral anticoagulant (NOAC) is superior to warfarin with good time in the therapeutic range (TTR) based on lower INR target among Asians with NVAF remains unknown.<h4>Methods</h4>In this retrospective study collected from Taiwan Chang Gung Memorial Hospita  ...[more]

Similar Datasets

| S-EPMC8174352 | biostudies-literature
| S-EPMC6394450 | biostudies-literature
| S-EPMC8850709 | biostudies-literature
| S-EPMC6832302 | biostudies-literature
| S-EPMC6405244 | biostudies-literature
| S-EPMC7033848 | biostudies-literature
| S-EPMC11315758 | biostudies-literature
| S-EPMC6756330 | biostudies-literature
| S-EPMC6670242 | biostudies-literature
| S-EPMC7019404 | biostudies-literature